Old Web
English
Sign In
Acemap
>
authorDetail
>
Sarah-Jane Anderson
Sarah-Jane Anderson
GlaxoSmithKline
Medicine
cost effectiveness
Internal medicine
human immunodeficiency virus
Abacavir
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-Effectiveness of Juluca (dolutegravir/rilpivirine) for Human Immunodeficiency Virus (HIV-1) Infection Treatment in Virologically Suppressed Adults in Taiwan.
2021
Value in health regional issues
Sarah-Jane Anderson
Chiung-Yuan Hsu
Huang-Tz Ou
Nai-Ying Ko
Chun Ting Yang
Sara Lopes
Show All
Source
Cite
Save
Citations (0)
Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States
2021
Journal of managed care & specialty pharmacy
Karin Butler
Sarah-Jane Anderson
Olivia Hayward
I. Jacob
Yogesh Punekar
Lee Alexandra Evitt
Alan Oglesby
Show All
Source
Cite
Save
Citations (0)
1018. Health Technology Assessment of New Long-Acting, Directly-Observed HIV Treatments in Canada: Impact of Real-World Adherence to Daily Oral Therapy on Treatment, Transmission and Cost-Effectiveness
2020
Open Forum Infectious Diseases
Erin Arthurs
Ben Parker
I. Jacob
Debbie Becker
Amy Lee
Olivia Hayward
Vasiliki Chounta
Sarah-Jane Anderson
Nicolas Van de Velde
Show All
Source
Cite
Save
Citations (0)
1